Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Organogenesis (ORGO) had Non-Operating Income/Expense of $0.96M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$86.69M |
|
$-21.59M |
|
$23.72M |
|
$62.97M |
|
$113.44M |
|
$-26.75M |
|
|
Non-Operating Income/Expense |
$0.96M |
$-25.78M |
|
$-25.78M |
|
$-18.84M |
|
$-18.84M |
|
$-18.84M |
|
$-18.84M |
|
$-26.75M |
|
$-20.46M |
|
126.30M |
|
126.30M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$268.16M |
|
$75.52M |
|
$199.23M |
|
$467.39M |
|
$65.05M |
|
$0.41M |
|
$159.44M |
|
$224.49M |
|
$242.90M |
|
$202.50M |
|
$242.90M |
|
126.85M |
|
| Cash Flow Statement Financials | |
$-19.93M |
|
$-3.63M |
|
$-2.06M |
|
$136.15M |
|
$110.53M |
|
$-25.62M |
|
$3.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.12 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
72.64% |
|
-30.85% |
|
-30.85% |
|
-- |
|
-29.74% |
|
-24.91% |
|
$-23.56M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
0.81 |
|
0.84 |
|
107.26 |
|
-7.76% |
|
-9.30% |
|
-4.03% |
|
-7.74% |
|
$1.91 |
|
$-0.19 |
|
$-0.16 |
|